BDX Stock Falls -9.2% In A 9-day Losing Spree On Lowered FY26 Guidance
Becton Dickinson (BDX) – a developer and manufacturer of medical supplies and diagnostic products – hit a 9-day losing streak, with cumulative losses over this period amounting to -9.2%. The company’s market cap has crashed by about $4.6 Bil over the last 9 days and currently stands at $46 Bil.
The stock has YTD (year-to-date) return of 5.1% compared to -1% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Lowered Fiscal 2026 Adjusted Earnings Guidance
- Adjusted EPS guidance for FY2026 lowered to $12.35-$12.65
- Analyst consensus was significantly higher at $14.72-$14.84
- Impact: Sustained Institutional Selling, Negative Investor Sentiment
[2] Multiple Analyst Price Target Reductions
- RBC Capital Markets cut its price target to $172 from $210
- JPMorgan Chase & Co lowered its price target to $175 from $190
- Impact: Increased Selling Pressure, Loss Of Investor Confidence
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in BDX stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced (For details, see Buy or Sell BDX).
But here is the real interesting point.
You are reading about this -9.2% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for BDX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | BDX | S&P 500 |
|---|---|---|
| 1D | -0.2% | 0.0% |
| 9D (Current Streak) | -9.2% | -1.5% |
| 1M (21D) | -11.2% | -2.4% |
| 3M (63D) | 2.8% | -1.6% |
| YTD 2026 | 5.1% | -1.0% |
| 2025 | -12.6% | 16.4% |
| 2024 | -5.4% | 23.3% |
| 2023 | -2.7% | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 21.0 S&P constituents with 3 days or more of consecutive gains and 121 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 21 | 44 |
| 4D | 0 | 30 |
| 5D | 0 | 16 |
| 6D | 0 | 9 |
| 7D or more | 0 | 22 |
| Total >=3 D | 21 | 121 |
Key Financials for Becton Dickinson (BDX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $20.2 Bil | $21.8 Bil |
| Operating Income | $2.9 Bil | $3.0 Bil |
| Net Income | $1.7 Bil | $1.7 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ4 | 2026 FQ1 |
|---|---|---|
| Revenues | $5.9 Bil | $5.3 Bil |
| Operating Income | $826.0 Mil | $662.0 Mil |
| Net Income | $493.0 Mil | $382.0 Mil |
The losing streak BDX stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.